- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 35/17 - Lymphocytes; Lymphocytes B; Lymphocytes T; Cellules tueuses naturelles; Lymphocytes activés par un interféron ou une cytokine
Détention brevets de la classe A61K 35/17
Brevets de cette classe: 12206
Historique des publications depuis 10 ans
|
422
|
585
|
820
|
1234
|
1515
|
1723
|
1929
|
1486
|
1296
|
54
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1170 |
519 |
| The Regents of the University of California | 19503 |
286 |
| The Trustees of the University of Pennsylvania | 4254 |
277 |
| Memorial Sloan-Kettering Cancer Center | 1889 |
216 |
| Iovance Biotherapeutics, Inc. | 316 |
216 |
| Board of Regents, The University of Texas System | 5613 |
213 |
| Juno Therapeutics, Inc. | 374 |
150 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2832 |
144 |
| The Board of Trustees of the Leland Stanford Junior University | 6239 |
139 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 895 |
106 |
| City of Hope | 958 |
103 |
| Cellectis | 406 |
101 |
| The General Hospital Corporation | 4645 |
99 |
| Baylor College of Medicine | 917 |
99 |
| Autolus Limited | 248 |
98 |
| Novartis AG | 11276 |
89 |
| Dana-Farber Cancer Institute, Inc. | 2536 |
89 |
| Kite Pharma, Inc. | 392 |
89 |
| Regents of the University of Minnesota | 2677 |
84 |
| Fred Hutchinson Cancer Center | 414 |
83 |
| Autres propriétaires | 9006 |